Advertisement

Pharmaceutical Research

, Volume 16, Issue 1, pp 37–41 | Cite as

Spleen Capture of Nanoparticles: Influence of Animal Species and Surface Characteristics

  • Marina Demoy
  • Jean-Paul Andreux
  • Colette Weingarten
  • Bruno Gouritin
  • Valérie Guilloux
  • Patrick Couvreur
Article

Abstract

Purpose. To investigate the influence of animal species and nanoparticle surface characteristics on the intrasplenic distribution of polystyrene nanoparticles.

Methods. Two types of fluorescent polystyrene nanoparticles (Estapor® and Fluoresbrite®), plain or coated, were used in mice and rats. First, a fluorimetric method was developed for nanoparticle tissue quantification. Then, intrasplenic distribution of plain or coated nanoparticles was studied using histological examination and image analysis. Finally, the role of direct interactions between nanoparticles and spleen capturing cells was assessed by in vitro binding assays, using incubation of thick spleen slices with polystyrene nanoparticles.

Results. The two types of polystyrene nanoparticles showed different levels of trapping: Fluoresbrite® nanoparticles were more efficiently trapped by the spleen than Estapor® nanoparticles, both in mice and rats. In mice, most of the injected nanoparticles were localized in the marginal zone of the spleen, involving a special population of capturing cells, while in rats, the predominant capture occured in the red pulp. In mice, coated nanoparticles were localized both in the marginal zone and in the red pulp, whereas the coating did not seem to change the intrasplenic distribution of the nanoparticles in rats.

Conclusions. These complementary approaches showed different uptake pathways of nanoparticles, according to their surface characteristics and the rodent species used.

spleen mouse nanoparticles quantification targeting surfactants 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    Y. Arakami, K. Akiyama, T. Hara, and S. Tsuchiya. Recognition of charged liposomes by rat peritoneal macrophages: effects of fibronectin on the uptake of charged liposomes. Eur. J. Pharm. Sci. 3:63–70 (1995).Google Scholar
  2. 2.
    D. Liu, A. Mori, and L. Huang. Large liposomes containing ganglioside GM1 accumulate effectively in spleen. Biochem. Biophys. Acta 1066:159–165 (1991).Google Scholar
  3. 3.
    S. S. Davis, L. Illum, S. M. Moghimi, C. J. H. Porter, A. Muir, A. Brindley, N. M. Christy, M. E. Norman, P. Williams, and S. E. Dunn. Microspheres for targeting drugs to specific body sites. J. Contr. Rel. 24:157–163 (1993).Google Scholar
  4. 4.
    S. M. Moghimi. Mechanisms of splenic clearance of blood cells and particles: towards development of new splenotropic agents. Adv. Drug Del. Rev. 17:103–115 (1995).Google Scholar
  5. 5.
    S. M. Moghimi, C. J. Porter, I. S. Muir, L. Illum, and S. S. Davis. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coatings. Biochem. Biophys. Res. Commun. 177(2):861–866 (1991).Google Scholar
  6. 6.
    S. M. Moghimi, H. Hedeman, L. Illum, and S. S. Davis. Effect of splenic congestion associated with haemolytic anaemia on filtration of' spleen-homing' microspheres. Clin. Sci. 84:605–609 (1993).Google Scholar
  7. 7.
    S. M. Moghimi, H. Hedeman, I. S. Muir, L. Illum, and S. S. Davis. An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in the rat spleen. Biophys. Biochem. Acta 1157:233–240 (1993).Google Scholar
  8. 8.
    C. J. Porter, S. M. Moghimi, L. Illum, and S. S. Davis. The polyoxyethylene/polyoxypropylene block co-polymer selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow. FEBS Lett. 305:62–66 (1992).Google Scholar
  9. 9.
    L. Illum, S. S. Davis, R. H. Müller, E. Mak, and P. West. The organ distribution and circulation tissue of intravenously injected colloïdal carriers sterically stabilized with a block co-polymer: poloxamine 908. Life Sci. 40:367–374 (1987).Google Scholar
  10. 10.
    S. M. Moghimi. Poloxamer 188 revisited: a potentially valuable immune modulator. J. Nat. Cancer Inst. 88:766–768 (1996).Google Scholar
  11. 11.
    S. M. Moghimi, H. Hedeman, N. M. Christy, L. Illum, and S. S. Davis. Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymozan-stimulated rats. J. Leuk. Biol. 54:513–517 (1993).Google Scholar
  12. 12.
    R. H. Müller, and K. H. Wallis. Surface modification of I.V. injectable biodegradable nanoparticles with poloxamers polymers and poloxamine 908. Int. J. Pharm. 89:25–31 (1993).Google Scholar
  13. 13.
    M. Demoy, S. Gibaud, J. P. Andreux, C. Weingarten, B. Gouritin, and P. Couvreur. Splenic trapping of nanoparticles: complementary approaches for in situ studies. Pharm. Res. 14:463–468 (1997).Google Scholar
  14. 14.
    L. Weiss. Mechanisms of splenic clearance of the blood; a structural overview of the mammalian spleen. In: A. J. Bowdler (ed), The spleen: structure, function and clinical significance. Chapman and Hall, London, 1990, pp. 25–35.Google Scholar
  15. 15.
    R. H. Müller, D. Rühl, M. Lück, and B. R. Paulke. Influence of fluorescent labelling of polystyrene particles on phagocytic uptake, surface hydrophobicity and plasma protein adsorption. Pharm. Res. 14:18–24 (1997).Google Scholar

Copyright information

© Plenum Publishing Corporation 1999

Authors and Affiliations

  • Marina Demoy
    • 1
  • Jean-Paul Andreux
    • 2
  • Colette Weingarten
    • 1
  • Bruno Gouritin
    • 2
  • Valérie Guilloux
    • 2
  • Patrick Couvreur
    • 1
  1. 1.Laboratoire de Physico-Chimie, Pharmacotechnie et Biopharmacie, URA CNRS 1218, Faculté de PharmacieUniversité Paris XI, 5Châtenay-Malabry cedexFrance
  2. 2.Laboratoire d'Hématologie, Faculté de PharmacieUniversité Paris XI, 5Châtenay-Malabry cedexFrance

Personalised recommendations